Valuation : IMAC Holdings, Inc.

Market Cap 526K 452K 426K 389K 727K 49.64M 729K 5.03M 1.95M 25.47M 1.97M 1.93M 82.04M P/E 2023
-0.26x
P/E 2024 -0.22x
Enterprise Value 21.54K 18.54K 17.44K 15.93K 29.8K 2.03M 29.89K 206K 79.97K 1.04M 80.89K 79.13K 3.36M EV / Sales 2023
-
EV / Sales 2024 28.5x
Free-Float
98.48%
Yield 2023 *
-
Yield 2024 -
1 day-11.63%
1 week+7,500.00%
Current month+7,500.00%
1 month+9,400.00%
3 months-11.63%
6 months-32.26%
Current year-72.64%
1 week 0
Extreme 0.0005
0.04
1 month 0
Extreme 0.0002
0.04
Current year 0
Extreme 0.0002
0.15
1 year 0
Extreme 0.0002
0.21
3 years 0
Extreme 0.0002
7.75
5 years 0
Extreme 0.0002
48
10 years 0
Extreme 0.0002
216.15
Manager TitleAgeSince
Chief Executive Officer 51 2024-05-22
Director of Finance/CFO 57 2019-04-29
Director TitleAgeSince
Director/Board Member 46 2020-10-20
Director/Board Member 66 2024-06-25
Director/Board Member 51 2024-06-25
Date Insider Type Main position Quantity % Market Cap. Importance
12/31/24 Free

Director

3,333 0.1936%
12/31/24 Free

Director

3,333 0.1936%
12/31/24 Free

Director

3,333 0.1936%
Change 5-day change 1-year change 3-year change Capi.($)
-11.63%+7,500.00%-47.22%-98.69% 1.89K
-0.63%-3.07%+14.16%+33.67% 17.37B
+1.60%-1.23%+12.87%+74.76% 13.17B
-0.65%+0.78%-3.02%+73.17% 12.01B
+1.45%+1.70%-35.06%-55.42% 11.58B
+0.76%-4.15% - - 10.1B
-0.76%-1.27%-1.84%+79.01% 9.87B
-0.97%+4.62%-2.86%-25.82% 9.86B
+1.78%+3.78%+57.04%+9.46% 8.68B
-0.38%-2.26%-9.41% - 7.93B
Average -0.97%-0.34%-1.70%+11.27% 10.06B
Weighted average by Cap. +0.20%-0.67%+3.84%+29.25%

Financials

2023 2024
Net sales - 72.05K 62K 58.33K 53.29K 99.68K 6.8M 99.95K 689K 267K 3.49M 271K 265K 11.24M
Net income -9.42M -8.1M -7.63M -6.97M -13.03M -889M -13.07M -90.11M -34.97M -456M -35.37M -34.6M -1.47B -9.05M -7.78M -7.32M -6.69M -12.52M -854M -12.55M -86.54M -33.58M -438M -33.97M -33.23M -1.41B
Net Debt -222K -191K -179K -164K -306K -20.91M -307K -2.12M -822K -10.73M -832K -814K -34.57M -504K -434K -408K -373K -698K -47.6M -699K -4.82M -1.87M -24.42M -1.89M -1.85M -78.68M
Logo IMAC Holdings, Inc.
IMAC Holdings, Inc. provides services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company, through its subsidiary, Ignite Proteomics LLC (Ignite Proteomics), leverages its multi-analyte proteomic assay to help oncologists pinpoint the effective targeted therapies for each patient. Its product is a patented Reverse Phase Protein Array (RPPA) technology platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. Ignite Proteomics operates a CLIA-certified and CAP-accredited laboratory and offers single-gene tests by evaluating entire protein pathways in cancer cells. Its commercially available lab developed test (LDT), the Ignite RPPA Assay for Breast Cancer, is being utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.
Employees
15
Date Price Change Volume
26-09-04 US$0.000500 -.--% 5,634

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BACK Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!